weight regain and cardiometabolic effects after withdrawal of semaglutide semaglutide: The STEP 1 trial extension Two-year effects of semaglutide in
Description
said on Thursday that it has added to its weight management support services for customers who are on or who are considering GLP-1 therapies.
: !GLP-1 ,
Taking ozempic for weight loss is a troubling part of diet culture, and anti-fat bias that can lead to disordered eating practices
Initiation of PERFORMA Phase 3 MASH trial planned for second half 2026 $535 million in cash, cash equivalents and short-term investments as of April 30, 2026 Webcast to be held today at 8:30 a.m
Thyroid disease doesn't automatically disqualify you from GLP-1 weight loss therapy, but careful medical oversight is essential
